新产业收盘上涨1.86%，滚动市盈率25.75倍，总市值473.71亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Shenzhen New Industry Biomedical Engineering Co., Ltd. in the medical device sector, particularly in the in vitro diagnostics field [1] - As of August 20, the company's stock closed at 60.29 yuan, with a PE ratio of 25.75, marking a 49-day low, and a total market capitalization of 47.371 billion yuan [1] - The average PE ratio for the medical device industry is 59.32, with a median of 39.97, placing the company at 49th in industry rankings [1][2] Group 2 - The company reported a revenue of 1.125 billion yuan for Q1 2025, reflecting a year-on-year increase of 10.12%, and a net profit of 438 million yuan, up 2.65% year-on-year, with a gross margin of 68.01% [1] - A total of 48 institutions hold shares in the company, with a combined holding of 33.4155 million shares valued at 1.895 billion yuan [1] - The company has received accolades such as the "National Brand Gold Award" for medical equipment in 2024, indicating high customer satisfaction and service quality, particularly in tertiary hospitals [1]